Strength of ddPCR-based Products, Including IVDR Certification, Strategic Collaborations in Molecular Residual Disease Monitoring, and Large Methylation Assay Library, Support Company’s Oncology Strategy
Vericheck ddPCR Empty-Full Capsid Kit Combines Measuring Viral Titer and Capsid Titer, Providing a High-Precision Assessment for Critical Quality Attributes of Both Protein and DNA in Droplets
Annexin V StarBrightTM Conjugates Offer Increased Choice and Flexibility for Apoptosis Detection in Conventional and Full Spectrum Flow Cytometry
Study Describes Method to Successfully Modify the Functional Activity of SpyCatcher Protein for the Rapid Generation and High-Throughput Screening of Bispecific Antibodies
New Service Enables Identification of Bispecific Antibody Candidates Accelerating Drug Development
Strategic Collaborations in Molecular Residual Disease Monitoring of Cancer and Product Launches in ddPCR Portfolio Advance Corporate Strategy in H1 2024
Bio-Rad launches ChemiDoc Go Imaging System - compact system uses CMOS digital imaging and is compatible with chemiluminescence and fluorescence detection and stain-free technology
New Celselect Slides™ 2.0 design, increases efficiency of circulating tumor cell capture from liquid biopsy samples for enumeration and downstream applications.
Bio-Rad launches four anti-idiotypic antibodies and a new anti-MMAE antibody range, enhancing bioanalytical assay development for preclinical research and clinical trials.
ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Analysis Software Enable High-Quality and Affordable Single-Cell Transcription and Gene Expression to Support Molecular Biology, Oncology, and Drug Discovery Research